Back to search
FDAFDA · Food and drugs·Recall number D-0381-2015

Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30

Published February 4, 2015 · Recall initiated: December 23, 2014

Summary

FDA records drug Class II recall D-0381-2015, published February 4, 2015 and initiated December 23, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 126,075 vials; Lot: Lot 35-844-DJ, Exp 11/01/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

What to do

Voluntary: Firm initiated · Letter

Get an email if PROPOFOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROPOFOL
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 35-844-DJ, Exp 11/01/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30 recalled?

Yes. FDA published recall D-0381-2015 on February 4, 2015. Reported hazard: Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROPOFOL.